Related Experiment Video
Updated: Jun 26, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Is peritoneal dialysis a suitable renal replacement therapy in autosomal dominant polycystic kidney disease?
1Division of Nephrology at Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium.
Insights
Peritoneal dialysis is a viable option for autosomal dominant polycystic kidney disease (ADPKD) patients, showing similar survival and peritonitis rates compared to non-diabetic controls. Further research should explore its suitability in patients with significantly enlarged kidneys or liver.
Area of Science:
- Nephrology
- Renal Replacement Therapy
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) management often involves renal replacement therapy.
- Peritoneal dialysis (PD) outcomes in ADPKD patients require further investigation.
Discussion:
- A study compared PD outcomes in 56 ADPKD patients with a matched control group.
- Key metrics included patient survival, technique survival, and peritonitis rates over a mean of 37 months.
- The study found comparable outcomes between ADPKD patients on PD and the control group.
Key Insights:
- Peritoneal dialysis was feasible and successful in 68% of ADPKD patients studied.
- No significant differences in patient survival, technique survival, or peritonitis rates were observed.
- The study suggests PD is a potentially effective treatment modality for ADPKD.
Outlook:
- The study did not compare PD with hemodialysis (HD) for ADPKD patients, particularly those with very large cystic kidneys or livers.
- Future research should investigate renal replacement modalities in ADPKD, correlating outcomes with kidney and liver volumes.
- Comparative studies are needed to determine the optimal renal replacement therapy for ADPKD patients with significant organ enlargement.
Abstract:
This commentary discusses a study reported by Kumar et al. that compared outcomes of 56 patients with autosomal dominant polycystic kidney disease (ADPKD) started on peritoneal dialysis with those of a control group of nondiabetic patients matched for age, sex and year of starting peritoneal dialysis. During follow-up (mean 37 months), patient survival, technique survival and peritonitis rates were similar in the two groups. Peritoneal dialysis was not only possible but was also successful in 68% of patients. Although the study was well conducted and the results very encouraging, it did not address the relevant clinical issue of whether peritoneal dialysis is a less desirable option than hemodialysis in some patients with ADPKD, for example those with very large, cystic kidneys and/or a very large, cystic liver. Further studies to investigate renal replacement modalities in patients with ADPKD should relate study outcomes to the volumes of patients' kidneys and liver.
Related Concept Videos
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

